Diego Chowell

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

30h-index9.4kcitations168works15.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(60), Salivary Gland Tumors Diagnosis and Treatment(57), Cell Adhesion Molecules Research(44), Neuroblastoma Research and Treatments(26), Renal cell carcinoma treatment(24)

Publications168 total

Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2025
Bone marrow CD57+ LGL cells comprised of NK and CD8 T cells drive bone marrow failure in Myelodysplastic Syndromes
Blood·2025Open Access
All models are wrong, but are some useful? Toward clinically tractable prediction of immunotherapy response in cancer
Immunotherapy·2025
Immunogenetics of cancer risk 3678
The Journal of Immunology·2025Open Access
Immunogenetics of cancer risk: an emerging role for HLA class II 2623
The Journal of Immunology·2025Open Access
34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
The Oncologist·2025Open Access
Restoring resident tissue macrophages to combat aging and cancer
Nature Aging·2025· 3 cited
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
iScience·2025· 1 citedOpen Access
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
Nature Medicine·2025· 79 citedOpen Access
Genetic immune escape in cancer: timing and implications for treatment
Trends in cancer·2024· 11 cited
What unique insights can modeling approaches capture about the immune system?
Cell Systems·2024· 3 cited
1441 Immune genetics and cancer risk
Regular and Young Investigator Award Abstracts·2024Open Access
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.
2024· 2 citedOpen Access
Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab
Nature Medicine·2024· 27 citedOpen Access
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features
Nature Cancer·2024· 88 citedOpen Access
Artificial intelligence
Cancer Cell·2024· 26 citedOpen Access
The electrostatic landscape of MHC-peptide binding revealed using inception networks
Cell Systems·2024· 5 citedOpen Access
An immunogenetic basis for lung cancer risk
Science·2024· 32 citedOpen Access
Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
Cancers·2023· 2 citedOpen Access
Unsupervised and supervised AI on molecular dynamics simulations reveals complex characteristics of HLA-A2-peptide immunogenicity
Briefings in Bioinformatics·2023· 9 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Timothy A. Chan(22), Luc G.T. Morris(14), Karen S. Anderson(12), Nadeem Riaz(11), Fengshen Kuo(11), Chirag Krishna(10), A. Ari Hakimi(8), Seong‐Keun Yoo(8), Cristina Valero(8), Vladimir Makarov(7), Vladimir Makarov(6), Robert Samstein(6), Lynda Vuong(6), Robert J. Motzer(6), Renzo G. DiNatale(5), Martin H. Voss(5), Mark Lee(5), Raghvendra M. Srivastava(4), Erich Sabio(4), Xiaoxiao Ma(4)